| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |